Skip to main
ACHC

Acadia Healthcare (ACHC) Stock Forecast & Price Target

Acadia Healthcare (ACHC) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 31%
Buy 23%
Hold 38%
Sell 8%
Strong Sell 0%

Bulls say

Acadia Healthcare Co Inc. is well-positioned for continued growth due to strong demand in the behavioral health sector, leading to impressive organic expansion through bed additions and new facility developments. The company's net PLGL liability is projected to rise significantly by the end of 2025, reflecting its robust operational capacity and strategic focus on mergers and acquisitions, bolstered by a solid capitalization structure. Furthermore, while faced with some rising costs and claims-related challenges, the guidance indicates an anticipated improvement in organic earnings growth, contributing to a favorable long-term outlook.

Bears say

Acadia Healthcare Co. has revised its guidance for 2025 downwards, reducing EBITDA expectations by approximately 13.4%, primarily due to higher-than-expected litigation expenses that are anticipated to persist into 2026. The company's projected FY26 EBITDA is now expected to be 5% below previous estimates, indicating ongoing challenges with volume softness and elevated operational costs. These factors collectively contribute to a negative outlook on Acadia's financial performance, with forecasted margins decreasing over a multi-year timeframe.

Acadia Healthcare (ACHC) has been analyzed by 13 analysts, with a consensus rating of Buy. 31% of analysts recommend a Strong Buy, 23% recommend Buy, 38% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Acadia Healthcare (ACHC) Forecast

Analysts have given Acadia Healthcare (ACHC) a Buy based on their latest research and market trends.

According to 13 analysts, Acadia Healthcare (ACHC) has a Buy consensus rating as of Apr 1, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $21.54, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $21.54, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Acadia Healthcare (ACHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.